Siklos
Active Ingredient(s): HydroxyureaFDA Approved: * December 21, 2017
Pharm Company: * ADDMEDICA SAS
Category: HIV / AIDS
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia and cervical cancer.[1][2] In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks.[1] It is taken by mouth.[1] Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches.... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.